Xcout Intel
AELIS FARMA
Aelis Farma is a biopharmaceutical company that develops novel treatments for brain diseases with unmet medical needs. It utilizes a unique class of pharmacological inhibitors, specifically signaling specific inhibitors of the CB1 receptor (CB1-SSi), to target conditions such as cannabis-related disorders and cognitive deficits associated with Down syndrome.
Subscribe to see AELIS FARMA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AELIS FARMA at a glance
AELIS FARMA is a biotech company headquartered in France. Xcout tracks 1 named person at AELIS FARMA, including Pier Vincenzo Piazza (CEO).
AELIS FARMA leadership
- Pier Vincenzo PiazzaCEO
Get AELIS FARMA's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on AELIS FARMA in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access